It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Multiple bacterial genera take advantage of the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin to invade host cells. Secretion of the MARTX toxin by Vibrio vulnificus, a deadly opportunistic pathogen that causes primary septicemia, the precursor of sepsis, is a major driver of infection; however, the molecular mechanism via which the toxin contributes to septicemia remains unclear. Here, we report the crystal and cryo-electron microscopy (EM) structures of a toxin effector duet comprising the domain of unknown function in the first position (DUF1)/Rho inactivation domain (RID) complexed with human targets. These structures reveal how the duet is used by bacteria as a potent weapon. The data show that DUF1 acts as a RID-dependent transforming NADase domain (RDTND) that disrupts NAD+ homeostasis by hijacking calmodulin. The cryo-EM structure of the RDTND-RID duet complexed with calmodulin and Rac1, together with immunological analyses in vitro and in mice, provide mechanistic insight into how V. vulnificus uses the duet to suppress ROS generation by depleting NAD(P)+ and modifying Rac1 in a mutually-reinforcing manner that ultimately paralyzes first line immune responses, promotes dissemination of invaders, and induces sepsis. These data may allow development of tools or strategies to combat MARTX toxin-related human diseases.
The MARTX toxins secreted by clinical V. vulnificus strains release the DUF1-RID effector duet in infected host cells. Here, the authors show that the duet hijacks calmodulin and Rac1, respectively, and transforms into a potent weapon to promote sepsis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Sciences, Daejeon, Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500); Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
2 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
3 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Chungnam National University, Department of Microbiology and Molecular Biology, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
4 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); KRIBB, Core Research Facility & Analysis Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
5 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); KAIST, Graduate School of Medical Science and Engineering, Daejeon, Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500)
6 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Chonnam National University, Department of Biology Education, Gwangju, Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399)
7 Korea Research Institute of Bioscience and Biotechnology (KRIBB), Microbiome Convergence Research Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Chungnam National University, College of Veterinary Medicine, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
8 KRIBB, Core Research Facility & Analysis Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099); Chungbuk National University, College of Pharmacy, Cheongju, Korea (GRID:grid.254229.a) (ISNI:0000 0000 9611 0917)
9 Ewha Womans University, Department of Food Science and Biotechnology, Seoul, Korea (GRID:grid.255649.9) (ISNI:0000 0001 2171 7754)
10 Korea Basic Science Institute, Cheongju, Korea (GRID:grid.410885.0) (ISNI:0000 0000 9149 5707)
11 KRIBB, Core Research Facility & Analysis Center, Daejeon, Korea (GRID:grid.249967.7) (ISNI:0000 0004 0636 3099)
12 Korea Advanced Institute of Science and Technology (KAIST), Department of Biological Sciences, Daejeon, Korea (GRID:grid.37172.30) (ISNI:0000 0001 2292 0500)